Baillie Gifford & Co
AFIB

Baillie Gifford & Co’s Acutus Medical Inc AFIB Stock Holding History

Baillie Gifford & Co’s Portfolio AFIB Stock Details AFIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-424
Closed -$320 – 447
2023
Q1 		$320 Hold
424
– – ﹤0.01% 451
2022
Q4 		$488 Hold
424
– – ﹤0.01% 485
2022
Q3 		$0 Hold
424
– – ﹤0.01% 500
2022
Q2 		$0 Hold
424
– – ﹤0.01% 515
2022
Q1 		$1K Hold
424
– – ﹤0.01% 495
2021
Q4 		$1K Hold
424
– – ﹤0.01% 498
2021
Q3 		$4K Hold
424
– – ﹤0.01% 485
2021
Q2 		$7K Hold
424
– – ﹤0.01% 456
2021
Q1 		$6K Buy
424
+6
+1% +$135 ﹤0.01% 431
2020
Q4 		$12K Buy
+418
New +$11.3K ﹤0.01% 374

Other funds holding AFIB

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $284M AUM 12.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

Baillie Gifford & Co's AFIB Position: Q2 2023 in Review

Baillie Gifford & Co sold out of Acutus Medical Inc (AFIB) in Q2 2023, closing a stake of 424 shares — an estimated $320 sold.

Baillie Gifford & Co first reported a position in AFIB in Q4 2020 and held it in 10 quarters. The position peaked at $12K in Q4 2020. 35 funds tracked by Wall St. Rank hold AFIB as of Q2 2023.

  • Baillie Gifford & Co reported no remaining Acutus Medical Inc position as of Q2 2023 after selling out during the quarter.
  • Baillie Gifford & Co sold 424 Acutus Medical Inc shares in Q2 2023, an estimated $320.
  • Baillie Gifford & Co first reported a position in Acutus Medical Inc in Q4 2020 and held it in 10 quarters.
  • Baillie Gifford & Co's Acutus Medical Inc position peaked at $12K in Q4 2020.
  • 35 funds tracked by Wall St. Rank held Acutus Medical Inc as of Q2 2023.

Based on Baillie Gifford & Co's 13F filing for Q2 2023, filed 28 Jul 2023.